Integrating Artificial Intelligence to Accelerate Development of Patient-Specific Cancer Vaccines

Nov 26, 2025 | 3:10 PM - 3:20 PM

Startup Stage

ΛI FOR HEALTH

Description

This session explores how Genevation’s Adapt AI platform leverages artificial intelligence to design personalized cancer vaccines within 14 days. By integrating genomic, transcriptomic, and immunological data, the platform enables rapid neoantigen discovery and vaccine optimization for individual patients. Dr. Prasun Chakraborty will discuss case studies demonstrating how AI-driven analytics are transforming oncology development, reducing timelines, and improving patient outcomes.

PRESENTED BY